Evidence map›Paper›PMID 33450863›Full record

ReviewInternational journal of molecular sciences2021

Oxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases.

Piotr Wójcik, Agnieszka Gęgotek, Neven Žarković, Elżbieta Skrzydlewska

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 4 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 4 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Live AirwayEnvironment & health (Washington, D.C.) · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Piotr WójcikDepartment of Analytical Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-4455-3788
Agnieszka GęgotekDepartment of Analytical Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.
Neven ŽarkovićLaboratory for Oxidative Stress, Rudjer Boskovic Institute, 10000 Zagreb, Croatia.ORCID 0000-0001-5032-0369
Elżbieta SkrzydlewskaDepartment of Analytical Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0001-5397-7139
Medical University of Białystok · PLRuđer Bošković Institute · HR

Funding

Narodowa Agencja Wymiany Akademickiej PPI/APM/2018/00015/U/001Narodowe Centrum Nauki 2016/23/B/NZ7/02350
6 · The paper itself

Abstract

Autoimmune diseases, including psoriasis, systemic lupus erythematosus (SLE), and rheumatic arthritis (RA), are caused by a combination of environmental and genetic factors that lead to overactivation of immune cells and chronic inflammation. Since oxidative stress is a common feature of these diseases, which activates leukocytes to intensify inflammation, antioxidants could reduce the severity of these diseases. In addition to activating leukocytes, oxidative stress increases the production of lipid mediators, notably of endocannabinoids and eicosanoids, which are products of enzymatic lipid metabolism that act through specific receptors. Because the anti-inflammatory CB2 receptors are the predominant cannabinoid receptors in leukocytes, endocannabinoids are believed to act as anti-inflammatory factors that regulate compensatory mechanisms in autoimmune diseases. While administration of eicosanoids in vitro leads to the differentiation of lymphocytes into T helper 2 (Th2) cells, eicosanoids are also necessary for the different0iation of Th1 and Th17 cells. Therefore, their antagonists and/or the genetic deletion of their receptors abolish inflammation in animal models of psoriasis-RA and SLE. On the other hand, products of non-enzymatic lipid peroxidation, especially acrolein and 4-hydroxynonenal-protein adducts, mostly generated by an oxidative burst of granulocytes, may enhance inflammation and even acting as autoantigens and extracellular signaling molecules in the vicious circle of autoimmune diseases.

Indexed as

ImmunomodulationLipid MetabolismOxidative StressAnimalsAutoimmune DiseasesHumansInflammation MediatorsReactive Oxygen SpeciesInflammation MediatorsReactive Oxygen Speciesendocannabinoidsimmunitylipid mediatorsoxidative stressprostaglandinspsoriasispsoriatic arthritisrheumatoid arthritisROSsystemic lupus erythematosus

Identifiers

PMID33450863
PMCPMC7828321
OpenAlexW3118492427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.